For many of China's biotech brains-in-exile, it's time to come home

February 12, 2015 9:49 PM

15 0

SHANGHAI (Reuters) - In biotech parks across the Yangtze River Delta, dozens of start-ups are working to develop drugs to treat China's biggest emerging diseases - from diabetes and Hepatitis B to respiratory illnesses and cancer.

It's early days, but firms like Hua Medicine and Innovent Biologics embody China's hopes for competitive biomedical innovation. And their Chinese-born, Western-educated founders represent the long-awaited return of the nation's brightest life scientists.

Also read: Spain Maintains Direct Rule Over Catalonia Due to ‘Provocative’ Regional Government

Read more

To category page